A detailed history of ETF Managers Group, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 10,857 shares of HLVX stock, worth $20,302. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,857
Holding current value
$20,302
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$14.73 - $18.18 $159,923 - $197,380
10,857 New
10,857 $179,000
Q3 2022

Nov 14, 2022

BUY
$10.5 - $22.01 $3,412 - $7,153
325 Added 3.41%
9,864 $169,000
Q2 2022

Aug 15, 2022

BUY
$8.7 - $20.18 $82,989 - $192,497
9,539 New
9,539 $97,000

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $62.5M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.